Mark Flather | VP of IR |
Shawn Singh | CEO |
Josh Prince | SVP of Business Operations |
Andrew Tsai | Jefferies |
Joanne Lee | Maxim Group |
Greetings, and welcome to the Vistagen Therapeutics Fiscal Year 2024 First Quarter Corporate Update Conference Call. [Operator Instructions] And as a reminder, this conference is being recorded, Thursday, August 10, 2023.
I would now like to turn the conference over to Mark Flather, Vice President of Capital Markets. Please go ahead.
Thank you, Jennifer.